These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 3160926

  • 21. [A clinical study of immunological status in patients with gastric cancer: with special reference to T-cell subsets, interleukin-2 in the lymphocytes of peripheral blood].
    Owada S.
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):52-61. PubMed ID: 2138244
    [Abstract] [Full Text] [Related]

  • 22. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [Abstract] [Full Text] [Related]

  • 23. Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.
    Berd D, Maguire HC, Mastrangelo MJ.
    Cancer Res; 1984 Mar; 44(3):1275-80. PubMed ID: 6229330
    [Abstract] [Full Text] [Related]

  • 24. In vitro generation of adherent mononuclear suppressor cells to Toxoplasma antigen.
    Luft BJ, Pedrotti PW, Remington JS.
    Immunology; 1988 Apr; 63(4):643-8. PubMed ID: 2966766
    [Abstract] [Full Text] [Related]

  • 25. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T, Kotani H, Takada S, Murakawa Y, Ueda Y.
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [Abstract] [Full Text] [Related]

  • 26. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer.
    Moroz C, Kupfer B.
    Isr J Med Sci; 1981 Aug; 17(9-10):879-81. PubMed ID: 6458580
    [Abstract] [Full Text] [Related]

  • 27. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO, Röder A, Fröhlich J.
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [Abstract] [Full Text] [Related]

  • 28. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK, Depew WT, Szewczuk MR.
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [Abstract] [Full Text] [Related]

  • 29. Radiosensitive, thymic hormone-sensitive peripheral blood suppressor cell activity in cancer patients.
    Hersh EM, Patt YZ, Murphy SG, Dicke K, Zander A, Adegbite M, Goldman R.
    Cancer Res; 1980 Sep; 40(9):3134-40. PubMed ID: 6448685
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
    Catalona WJ, Ratliff TL, McCool RE.
    J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
    [Abstract] [Full Text] [Related]

  • 32. Concanavalin A induced suppression of lymphocyte proliferation in chronic liver disease. A study of suppressor and responder populations in autologous and allogeneic systems.
    Arabi MA, Nouri-Aria KT, Alexander GJ, Eddleston AL, Williams R.
    J Clin Lab Immunol; 1985 Dec; 18(4):161-5. PubMed ID: 2937919
    [Abstract] [Full Text] [Related]

  • 33. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J, Jacobs P, Doffek K, Sugg SL.
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [Abstract] [Full Text] [Related]

  • 34. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C, Hartmann D, Landmann R, Wesp M, Rosenfelder G, Stucki D, Buser M, Obrecht JP.
    Schweiz Med Wochenschr; 1983 Dec 17; 113(50):1908-11. PubMed ID: 6229873
    [Abstract] [Full Text] [Related]

  • 35. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
    Minassian AA, Kadagidze ZG.
    Neoplasma; 1983 Dec 17; 30(2):153-8. PubMed ID: 6221196
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J.
    Dan Med Bull; 1988 Apr 17; 35(2):140-57. PubMed ID: 3282810
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2.
    Pawelec G, Schwuléra U, Lenz H, Owsianowski M, Bühring HJ, Schlag H, Schneider E, Schaudt K, Ehninger G.
    Mol Biother; 1990 Mar 17; 2(1):44-9. PubMed ID: 2139787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.